Head-to-head · Cost-Efficiency Index
Blue Haven RX vs FitFlow
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Blue Haven RX
Shoppers who read the FAQ carefully before trusting the homepage price.
Visit Blue Haven RXFitFlow
Cost-first shoppers who want price-sensitive shoppers comfortable calling to confirm whether the FLOW25 promo price is durable.
Visit FitFlowThe verdict
Blue Haven RX and FitFlow tie on the Cost-Efficiency Index at 61/100, so neither wins outright on the numbers. For most shoppers we'd start with Blue Haven RX (ranked #225, a hair above #227) — Shoppers who read the FAQ carefully before trusting the homepage price. But FitFlow is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Blue Haven RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Blue Haven RX | FitFlow |
|---|---|---|
| Cost-Efficiency Index | 61/100 | 61/100 |
| Semaglutide / mo | $149/mo (all doses, compounded) | $99/mo (compounded) |
| Tirzepatide / mo | $179/mo (all doses, compounded) | $134/mo (compounded) |
| Semaglutide / yr (modeled) | $1,788 | $1,188 |
| Tirzepatide / yr (modeled) | $2,148 | $1,608 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #225 | #227 |
Blue Haven RX
61/100Where the value is
- Claims flat, dose-independent pricing ('no price increases' regardless of dose)
- Routes to established physician networks (Wasef Health, Beluga Health) rather than an unknown in-house provider
- Payments held until doctor approval, per site copy, reducing risk of paying for a declined prescription
The tradeoffs
- Internal pricing contradiction: homepage says tirzepatide is $179/month, FAQ says $259/month
- No named medical director
FitFlow
61/100Where the value is
- LegitScript certified
- Transparent regular pricing displayed upfront without requiring an account
- Multiple payment options including Klarna financing
The tradeoffs
- Promo pricing (FLOW25) is undisclosed in duration -- classic 'limited time' ambiguity
- No named medical director found anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.